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Background: Leucyl-tRNA synthetase (LeuRS) is one of the essential enzymes belonging to the family of aminoacyl-
tRNA synthetases (aaRSs), which executes the translation of genetic code by catalyzing the specific attachment of
amino acids to their cognate tRNAs. This process is very crucial for survival of micro-organism and thus the
inhibition of LeuRS offered a novel and lucrative target for developing new antimicrobials.
Findings: Docking studies using hybrid phenylthiazole-1,3,5-triazine derivatives revealed that these molecules acted
as probable inhibitors of candida albicans cytosolic leucyl-tRNA synthetase.
Conclusion: The conjugates of phenylthiazole and 1,3,5-triazine can act as lead molecules towards the
development of potential leucyl-tRNA synthetase inhibitors on the basis of molecular docking runs, which
contribute to the possible mechanism of antifungal activity of these analogues.
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Infections caused by opportunistic pathogenic fungi, es-
pecially candida species, cryptococcus neoformans and
aspergillus fumigates are associated with high morbidity
and mortality in immunocompromised patients (Pfaller
and Diekema, 2004). Additionally, the dramatic rise in the
prevalence of fungal resistance, currently poses a serious
threat to public health worldwide (Ghannoum and Rice,
1999; Pfaller 2012). However, combined with improve-
ments in performances, standardization of antifungal sus-
ceptibility testing and new drug discovery have drawn
attention to the problem of antifungal resistance (Vanden
Bossche et al., 1998).
Aminoacyl-tRNA synthetase (aaRS) enzymes have re-
cently gained focus of attention as novel potential
target for antimicrobial drug research (Pohlmann and
Brötz-Oesterhelt, 2004). They perform a crucial role in* Correspondence: udaysingh98@gmail.com; singhramk@rediffmail.com
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in any medium, provided the original work is ptranslating the genetic code by catalyzing the specific at-
tachment of amino acids to their cognate tRNAs in a
two step reaction: activation of amino acid with ATP to
form enzyme-bound aminoacyl-AMP (with release of
pyrophosphate), and transfer of amino acid moiety to cog-
nate tRNA, releasing AMP and charged tRNA (Figure 1).
Based on the architecture of their catalytic domains, aaRSs
belong to two distinct classes. Class I enzymes contain a
typical Rossman fold in the active site, with the HIGH and
KMSKS motifs that stabilize the transition state of the
reaction for amino acid activation using ATP-binding
energy. Class II enzymes harbor an antiparallel β-sheet do-
main that provides a rigid template for amino acid and
ATP binding, with three characteristic motifs required for
dimerization and substrate binding (Hurdle et al. 2005). A
newly discovered antifungal agent AN2690, (under clinical
investigation) reported to act by inactivating fungal LeuRS,
a class I aaRS enzyme is responsible for charging leucine
to its cognate tRNA correctly (Kim et al. 2003). As a re-
sult, design and discovery of LeuRS inhibitors surfaces as
a prolific approach to attenuate microorganism growth for
exploring novel antifungal agents via arrest of fungal
protein synthesis (Hendrickson et al. Hendrickson and
Schimmel 2003; Rock et al., 2007).Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 Role of aminoacyl-tRNA synthetase (aaRS) enzyme in translating the genetic code by catalyzing the specific attachment of
amino acids to their cognate tRNAs.
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tool in systems biology and computer-assisted drug discov-
ery. It is used to predict the preferred orientation, affinity
and activity of ligands (small molecules) into the active site
of target protein through a process involving series of steps.
In continuation of our research endeavour on discovery of
novel anti-infective agents from 1,3,5-triazines (Gahtori
et al. 2009; Singh et al. 2011; Bhat et al. 2011; Gahtori et al.
2012a; Gahtori et al. 2012b; Gahtori and Ghosh et al. 2012;
Ghosh et al. 2012; Bhat et al. 2012, Singh et al. 2012). We
have tried to work out the inhibitory effect of hybrid phe-
nylthiazole-1,3,5-triazines on the candida albicans cytosolic
leucyl-tRNA synthetase editing domain through molecular
docking studies to elucidate probable mechanism of action
of 1,3,5-triazine as antifungal agent.
Experimental
Molecular docking studies
The 3D X-ray crystal structure of benzoxaborole-AMP
adduct docked into the candida albicans cytosolic leucyl-
tRNA synthetase editing domain was used as a target
protein model for this study (2wfg.pdb). All computa-
tional analyses were carried out using Discovery Stu-
dio 2.5 (DS 2.5, Accelrys Software Inc., San Diego; http://
www.accelrys.com).
Preparation of receptor
The target protein complexed with benzoxaborole-AMP
adduct was taken, the ligand benzoxaborole-AMP adductextracted, and the bond orders were corrected. The
hydrogen atoms were added, their positions optimized
using the all-atom CHARMm (version c32b1) forcefield
with Adopted Basis set Newton Raphson (ABNR)
minimization algorithm until the root mean square (r.m.s)
gradient for potential energy was less than 0.05 kcal/mol/Å
(Brooks et al. 1983; Momany and Rone 1992). Using the
'Binding Site' tool panel available in DS 2.5, the minimized
candida albicans cytosolic leucyl-tRNA synthetase editing
domain was defined as receptor, and binding site was
defined as volume occupied by the ligand in the receptor,
with a radius of 5 Å. The centre of the sphere was taken to
be the centre of the binding site shape, and side chains of
the residues in the binding site within the radius of the
sphere were assumed to be flexible during refinement of
post-docking poses.
Ligand setup
Using the built-and-edit module of DS 2.5, the hybrid
molecules of phenylthiazole and 1,3,5-triazine were built,
all-atoms CHARMm forcefield parameterization assigned
and then minimized using the ABNR method. A conform-
ational search of the ligand was carried out using a stimu-
lated annealing molecular dynamics (MD) approach.
These ligands were heated to a temperature of 700 K and
then annealed to 200 K. Thirty such cycles were carried
out. The transformation obtained at the end of each cycle
was further subjected to local energy minimization, using
the ABNR method. The 30 energy-minimized structures
Table 1 Interaction generated between ligand-receptor after docking
Sample H-bonding Pi-cation monitor
Bond Distance* Donor atom Acceptor atom Bond Distance* End1 End2
1 1:H30 –ASP422:OD1 2.34 H30 OD1 1 - Lys483:NZ 4.24 1 NZ
1 - Lys483:NZ 5.40 1 NZ
2 Lys483:HZ3: 2:N14 2.45 HZ3 N14 1 - Lys483:NZ 4.78 2 NZ
2: H30 – ASP422:OD1 2.30 H30 OD1 1 - Lys483:NZ 4.30 2 NZ
3 3:H32 – ASP422 2.09 H32 OD1 3 – Lys 483:NZ 4.23 3 NZ
3 - Lys407:NZ 5.01 3 NZ
3 - Lys483:NZ 5.36 3 NZ
4 LYS407:HZ2 - N3: 4 2.03 HZ2 N3 4 - LYS483:NZ 3.46 4 NZ
LYS483:HZ3 - N5: 4 2.42 HZ3 N5
4:H32 - ASP421:OD2 1.28 H32 H32
5 NO NO 5 -Lys483:NZ 3.46 5 NZ
6 LYS483:HZ1 – N1 1.87 HZ1 N1 6 - LYS483:NZ 3.16 6 NZ
LYS483:HZ1 - N14 2.08 HZ1 N14 6 - LYS407:NZ 3.71 6 NZ
LYS483:HZ2 – N14 2.28 HZ2 N14 6 - LYS483:NZ 4.61 6 NZ
7 LYS407:HZ1- N5:7 2.40 HZ1 N5 7- LYS483:NZ 3.72 7 NZ
LYS407:HZ2 – N14:7 2.35 HZ2 N14 7 - LYS407:NZ 3.75 7 NZ
LYS407:HZ3 – N5:7 2.21 HZ3 N5 7 - LYS483:NZ 4.93 7 NZ
8 NO 8 - LYS483:NZ 3.19 8 NZ
8 - LYS407:NZ 3.94 8 NZ
8 - LYS483:NZ 4.46 8 NZ
8 - LYS407:NZ 5.40 8 NZ
8 - LYS407:NZ 4.91 8 NZ
9 LEU317:HN – O47:9 1.89 HN O47 9 - LYS407:NZ 3.13 9 NZ
LYS407:HZ1 –N1:9 2.40 HZ1 N1 9 - LYS407:NZ 3.00 9 NZ
LYS407:HZ2 – N14:9 1.61 HZ2 N14 9 - LYS483:NZ 3.55 9 NZ
LYS407:HZ3 – N1:9 1.99 HZ3 N1
10 LYS407:HZ2 – N14:10 2.089 HZ2 N14 10 - LYS483:NZ 3.43 10 NZ
LYS483:HZ1 –N5:10 2.276 HZ1 N5 10 - LYS407:NZ 4.42 10 NZ
10 - LYS483:NZ 5.29 10 NZ
11 LYS407:HZ2 - N14: 11 1.97 HZ2 N14 11 - LYS483:NZ 3.44 11 NZ
LYS483:HZ1 - N5: 11 2.00 HZ1 N5 11 - LYS483:NZ 4.09 11 NZ
11 :H41 - TYR487:OH 1.78 H41 OH 11 - ARG318:NE 5.74 11 NE
11 - LYS407:NZ 3.72 11 NZ
11- LYS407:NZ 4.75 11 NZ
12 ARG318:HH11 - O41: 12 1.79 HH11 O34 12 - LYS483:NZ 4.16 12 NZ
LYS407:HZ2 - N14: 12 2.39 HZ2 N14 12 - LYS483:NZ 4.48 12 NZ
SER476:HG -O34: 12 1.63 HG O34 12 - LYS407:NZ 3.93 12 NZ
12 - LYS483:NZ 5.99 12 NZ
13 13 :N7 - ALA315:O 3.18 N7 ALA315:O 13 - LYS483:NZ 4.18
13:N8 - TYR487:OH 2.60 N8 TYR487:OH 13 - LYS407:NZ 4.23
13 - LYS407:NZ 3.82
14 LYS483:HZ1 – N5: 14 2.36 HZ1 N5 14 - LYS483:NZ 3.73 14 NZ
14:N8 - TYR487:OH 2.56 N8 OH 14 - LYS407:NZ 4.24 14 NZ
14 - LYS407:NZ 3.50 14 NZ
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Table 1 Interaction generated between ligand-receptor after docking (Continued)
15 LYS407:HZ2 - N14: 15 2.88 HZ2 N14 15 - LYS483:NZ 3.33 15 NZ
SER476:HG -O37: 15 1.91 HG O37 15 - LYS407:NZ 5.18 15 NZ
LYS483:HZ1 - N5: 15 2.20 HZ1 N5
TYR487:HH - N3: 15 2.44 HH N3
*: Distance in Å.
Table 2 Scoring profile of ligands
Name -PLP1 -PLP2 -PMF Lig-internal_energy Dock score
1 82.49 61.74 62.31 -3.95 63.31
2 68.04 60.34 106.12 -5.50 61.94
3 78.68 67.35 106.87 -3.75 60.99
4 72.98 66.45 86.17 -3.31 63.77
5 71.74 68.03 91.95 -4.38 67.40
6 78.73 62.82 99.99 -4.79 60.00
7 45.01 47.38 42.44 -10.55 67.62
8 125.57 126.27 153.2 -10.20 61.60
9 42.84 43.3 93.07 -6.62 50.58
10 89.98 86.07 126.84 -7.76 67.88
11 97.75 94.22 128.93 -6.95 74.25
12 93.01 82.13 144.09 -1.94 56.43
13 101.68 85.74 121.12 -7.60 73.01
14 106.93 94.21 117.26 -7.82 75.68
15 85.8 80.86 117.03 -7.44 74.28
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ation occurring in the major cluster was taken to be the
most probable conformation.
Docking and scoring
LigandFit (Venkatachalam et al. 2003) protocol of DS
2.5 was used for the docking of ligands with candida
albicans cytosolic leucyl-tRNA synthetase editing domain.
The LigandFit docking algorithm combines a shape com-
parison filter with a Monte Carlo conformational search
to generate docked poses consistent with the binding site
shape. These initial poses are further refined by rigid body
minimization of the ligand with respect to the grid based
calculated interaction energy using the Dreiding forcefield
(Mayo et al. 1990). The receptor protein conforma-
tion was kept fixed during docking, and the docked
poses were further minimized using all-atom CHARMm
(version c32b1) forcefield and smart minimization method
(steepest descent followed by conjugate gradient) until
r.m.s gradient for potential energy was less than 0.05 kcal/
mol/Å. The atoms of ligand and the side chains of the
residues of the receptor within 5 Å from the centre of the
binding site were kept flexible during minimization. Fi-
nally, binding affinity of ligand towards the target protein
were determined on the basis of scoring parameter PLP1
(Gehlhaar et al. 1995), PLP2 (Gehlhaar et al. 1999), PMF
(Muegge and Martin 1999), Lig Internal Energy and Dock
Score in post-docked pose of ligand. Results are presented
in Tables 1 and 2.
Results and discussion
Docking
Till date a very few leucyl-tRNA synthetase inhibitors
have been reported as antifungal agents. One such mol-
ecule AN2690, a benzoxaborole derivative as potent non-
competitive inhibitor is under development. In the present
study, molecular docking studies of hybrid phenylthiazole-
1,3,5-triazine derivatives have been carried onto the
binding site of candida albicans cytosolic leucyl-tRNA
synthetase editing domain to exemplify the orientation &
binding affinity, and Dockscores calculated from the
docked conformations of the thymidylate synthetase -in-
hibitor complexes using LigandFit within DS 2.5. Docking
results were discussed on the parameters such as hyd-
rogen bond, pi-pi(hydrophobic) and non-polar pi-cation
(non-covalent) interactions. According to Gallivan andDougherty, pi-cation interaction energies are considered
of the same order of magnitude as hydrogen bonds or salt
bridges and play an important role in molecular recogni-
tion and interaction with ligands. These interactions of
the title compounds have been discussed, if the intera-
tomic distance fell below 6 Å (Gallivan and Dougherty
1999). Considering the magnitude of interacting forces for
receptor-ligand interaction, the entire set of molecules
were rigorously docked onto the active site of thymidylate
synthetase, using the same protocol and analyzed through
above mentioned parameters and results presented in
Figure 2 (compounds 1-8) and Figure 3 (compounds 9-15),
Tables 1 and 2.
It was revealed that entire molecules interacted in
similar fashion with thymidylate synthetase by making
use of hydrogen bonding and pi-cation interaction with
considerable affinity, albeit, no pi-pi interactions were
observed. From Table 1, two pi-cation interactions have
been reported with compound 1 having iso-propyl ami-
ne connected to triazine and Lys483 involving phenyl
of thiazole and 1,3,5-triazine with a distance of 4.24 Å
and 5.24 Å, respectively. Additionally, formation of one
hydrogen bond was also reported through hydrogen of
amine connecting thiazole to 1,3,5-triazine. Introduction
of 4-chloro at the phenyl connected to thiazole
Figure 2 Docked pose of compounds 1-8 in Leu-tRNA synthetase.
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Figure 3 Docked pose of compounds 9-15 in Leu-tRNA synthetase.
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thiazole and Lys483, as observed with compound 2.
On replacing 4-chloro with 4-NO2, compound 3 the
additional H-bond created earlier was lost and new pi-
cation interactions were observed between phenyl of thia-
zole and Lys407. Further, di-substitution of 1,3,5-triazine
with morpholine fragment in compound 4 (intact phenyl
on thiazole) yielded three hydrogen bonds, two using 3rd
and 5th nitrogen of triazine with Lys407 (2.03 Å) and
Lys483 (2.53 Å), and third using hydrogen connecting
thiazole to triazine with Lys483(3.46 Å). Surprisingly, no
hydrogen bond was reported in the case of compound 5
but for a single pi-cation interaction with 1,3,5-triazine
and Lys483 (3.46 Å). Presence of 4-NO2 at phenyl of thia-
zole, compound 6, led to the generation of three hydro-
gen bonds with Lys483, two with nitrogen of thaizole
(2.08 and 2.28 Å) and last H-bond with nitrogen of
triazine (1.87 Å). Three pi-cation interactions were
also reported in the case of compound 6, of which
two with Lys 483 using 1,3,5-triazine and phenyl of
thiazole with effective distance of 3.16 and 4.61 Å, re-
spectively and the last using thiazole with Lys407 (3.71
Å). Three hydrogen and pi-cation interactions were dis-
played by compound 7 having diphenyl amine attached to
both wings of 1,3,5-traizine. Lys 407 is the only amino acid
responsible for generation of all three hydrogen bonds,
two with nitrogen of 1,3,5-triazine (2.40 Å and 2.21 Å)
and the last hydrogen bond through nitrogen present in
thiazole (2.35 Å). While, two pi-cation interactions were
observed through the involvement of one of the phenyl
ring connected to 1,3,5-triazine with Lys407 (3.75 Å) and
Lys483 (4.93 Å) and other by thiazole with Lys483 (3.72
Å). Markedly, no hydrogen bond was revealed by com-
pound 8, (introduction of 4-cholro in phenyl of thiazole),
albeit reported formation of five pi-cation bonds with
Lys407 (with thiazole, 3.94 Å; phenyl of 1,3,5-triazine, 5.40
Å and phenyl of thiazole, 4.91 Å) and Lys483 (with 1,3,5-
triazine, 3.19 Å and phenyl of 1,3,5-triazine 4.46 Å) were
observed. The H-bond formation with protein target was
restored on replacing 4-Cl with 4-NO2 resulting in the
formation of additional hydrogen bonds by Leu317 with
oxygen of 4-NO2 on phenyl of thiazole and four by
Lys407 with nitrogen of 1,3,5-triazine (1.99 Å, 2.04 Å) and
nitrogen of thiazole (1.61 A), as observed in compound 9.
Introduction of di-halogen substituted phenyl amine on
both the faces of 1,3,5-triazine (10), led to creation of two
hydrogen bonds (nitrogen of thiazole with Lys407, 2.08 Å
and 5th nitrogen of 1,3,5-triazine) and three pi-cation
interactions of which two by Lys483 with 1,3,5-triazine
(3.43 Å) and phenyl of thiazole (5.29 Å), and the last one
through di-halogen substituted phenyl amine of 1,3,5-tria-
zine amid Lys407. Insertion of 4-NO2 in the place of 4-Cl
on phenyl thiazole ring (11) led to an additional H-bond
formation by Tyr487 (OH) through amine bridgeconnecting 1,3,5-triazine and pi-cation through Arg318
with phenyl of 1,3,5-triazine (5.74 Å). Amino acid resi-
dues, Arg315 and Ser476 were responsible for creation of
two H- bonds with compound 12, bearing 4-NO2 on
phenyl amine ring connected to 1,3,5-triazine system
(1.79 Å and 1.63 Å respectively). The amine bridge
connecting distant 4-fluoro phenyl amine to 1,3,5-
triazine (13) resulted in the formation of two hydrogen
bonds will Ala315 (2.60 Å) and Tyr457 (3.68 Å). Further-
more, the compound 13 also exhibited three pi-cation
interactions through involvement of Lys407 (thiazole, 4.23
Å and 4-fluoro phenyl amine of 1,3,5-triazine, 4.38 Å) and
Lys483. The compound 14 formed two hydrogen bonds
with Lys407 and Ser476 through nitrogen of 1,3,5-triazine
and amine bridge connecting 4-chloro phenyl amine to
1,3,5-triazine (2.36 Å and 2.56 Å, respectively). On the
other hand, it also displayed two pi-cation interactions
with Lys407 (with thiazole, 4.24 Å and 4-chloro phenyl
amine connected to 1,3,5-triazine, 3.50 Å) and Lys483
through 1,3,5-triazine with interatomic distance of 3.73 Å.
No considerable change in hydrogen bond and pi-cation
interaction was observed on replacing 4-chloro with 4-
bromo except one hydrogen bond through nitrogen of
1,3,5-triazine with Tyr487 (2.44 Å) as in the case of
compound 15. However, it displayed two pi-cation inter-
actions by means of Lys407 (3.50 A and 5.18 Å) and
Lys483 (3.33 Å).
From post-docked posses of ligands obtained from doc-
king, it was inferred that molecules were deeply buried
and stabilised into the active site of candida albicans cy-
tosolic leucyl-tRNA synthetase editing domain through
prolific intriguing attractions by hydrogen bonds and pi-
cation interactions. For majority of molecules, Lys483,
Lys407 and Asp422 were identified as key protein residues
responsible for generation of hydrogen bonds and
Asp421, Leu317, Arg318, Ser476, Ala315 and Tyr487 for
minor interaction. Whereas, for pi-cation interactions, it
were observed that Lys407 and Lys483 were the only res-
ponsible residues. Amine bridge, thiazole, 1,3,5-triazine,
substituted phenyl connected to thiazole and 1,3,5-triazine
were worked out as major structural features imperative
for interactions.
Scoring
Piecewise Linear Potential (PLP) is a fast and simple
docking function that has been shown to correlate well
the structural features with protein ligand binding af-
finities. Higher PLP scores indicate stronger receptor-
ligand binding. Two versions of the PLP function are
available: PLP1 and PLP2. In order to better define bind-
ing affinity of ligands with receptor, post-docked ligand-
receptor pose was evaluated on the basis of scoring
parameters like PLP1, PLP2, PMF, ligand internal energy
and dock score. These molecules were reported to show
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by PLP scores ranging from 42.84 (compound 9) to
106.93 (compound 14). The PMF scoring functions were
developed based on statistical analysis of the 3D struc-
tures of protein-ligand complexes. These were found to
correlate well with protein-ligand binding free energies
while being fast and simple to calculate. As depicted in
the Table 2, molecules having halogen substituted phenyl
amine connected to 1,3,5-triazine nucleus, showed higher
PMF values than their counterparts. The internal non-
bonded ligand energy is also calculated for each new con-
formation generated. It consists of a van der Waals (vdW)
term and an optional electrostatic term. All molecules dis-
closed optimum energy level, however, the Compound 7
(-10.55) and 8 (-10.20) were more stabilised. Lastly, candi-
date ligand poses were evaluated and prioritized according
to the dock score function and the entire dataset revealed
extensive score value ranging from 50.58 (9) to 75.68 (14).
Conclusion
In conclusion, hybrid phenylthiazole-1,3,5-traizine de-
rivatives may act as candida albicans cytosolic leucyl-
tRNA synthetase inhibitors on the basis of molecular
docking runs which contribute to the possible mecha-
nism of antifungal activity of these analogues. These mole-
cules were energetically proficient enough to make stable
contacts with target protein on account of effective hydro-
gen bond and pi-cation interactions, which was also sup-
plemented through scoring parameters.
In the light of above observation, the conjugates of
phenylthiazole and 1,3,5-triazine can act as a lead to-
wards the development of potential leucyl-tRNA synthe-
tase inhibitors, albeit, a considerable amount of work is
still required in this direction and it is in progress in our
laboratory and will be reported subsequently in future.
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